MMP2 and lung carcinoma: In lung cancer, its reduced expression is significantly associated with poor prognosis, and restoring its expression can inhibit proliferation and expression of invasion-related key molecules (such as MMP2, MMP9, cyclin D1) and block clonogenic formation [3,44,49].